Late last month, Firefly announced that Northrop Grumman has invested $50 million into accelerating the development of the ...

Additional support came from Abingworth, Invus, Tenmile, Vida Ventures, Vinyanshu Ventures and Willett Advisors.

The waxing gibbous moon will shine close to the red star Antares in the constellation Scorpius on the night of June 9.

Antares Therapeutics, Inc. ("Antares"), a biotechnology company developing first-in-class precision medicines for cancer and ...

The spinout, dubbed Antares Therapeutics, will be fueled by a $177 million series A round co-led by Omega Funds, Atlas ...

Ares Management is backing the continuation fund, an increasingly popular tool for private-credit managers to return cash to ...

On the evening of June 9, skywatchers will be treated to a beautiful cosmic pairing. The waxing gibbous moon will glow close ...

Boston, USA-based biotech Antares Therapeutics, launched yesterday with $177 million in Series A financing. Antares is a spin ...

Five months after selling a cancer drug to Lilly for up to $2.5 billion, Scorpion has debuted a successor company led by its ...

The global Track and Trace Solutions Market, valued at US$6.20 billion in 2024 stood at US$6.96 billion in 2025 and is ...

Antares Capital and Ares Management Corporation ("Ares") (NYSE: ARES) today announced the closing of Antares’ first continuation vehicle with over $1.2 billion in commitments. The transaction was led ...